Patients with AFR ancestry < 50% | Patients with AFR ancestry ≥ 50% | p value | |
---|---|---|---|
n | 1194 | 85 | |
Gender, n (% female) | 691 (57.9) | 48 (56.5) | 0.8 |
Age, years | 32 [16] | 31 [14] | 0.84 |
Duration of diabetes, (years) | 16 [12] | 13 [9.5] | 0.09 |
Weight (kg) | 66 [17.1] | 67.5 [21.2] | 0.39 |
Self-reported color-race, n (%) | < 0.001 | ||
White | 710 (59.5) | 7 (8.2) | |
Black | 68 (5.7) | 40 (47.1) | |
Brown | 397 (33.2) | 37 (43.5) | |
Asian | 12 (1) | 0 | |
Indigenous | 7 (0.6) | 1 (1.2) | |
Geographic region, n (%) | < 0.001 | ||
Southeast | 595 (49.8) | 31 (36.5) | |
South | 176 (14.7) | 7 (8.2) | |
North/northeast | 286 (24) | 40 (47.1) | |
Mid-West | 137 (11.5) | 7 (8.2) | |
Use of renin-agiotensin system blockers (n, %) | 378 (31.9%) | 40 (47%) | 0.004 |
Statin use (n, %) | 320 (26.8%) | 21 (24.7%) | 0.673 |
Genomic ancestry, % | |||
African | 14.0 [20.6] | 61 [12] | < 0.001 |
European | 69.8 [28.7] | 27 [17] | < 0.001 |
Amerindian | 10 [16.2] | 9 [8.4] | 0.367 |
Renal function, n (%) | 0.44 | ||
Normal (eGFR ≥ 60 ml/min) | 853 (71.4) | 62 (73) | |
CKD | 341 (28.6) | 23 (27) |